MRD / Regn No. : THBC\23-24\02244 Date : 16/06/2026
Patient Name : Bhakti Vaid Age & Gender : 32 Yrs. / Female
Contact No. : 9137349119 UHID :
Ht / Wt / BMI : 166.2 / 79.8 / 28.89 BP S / BP D : 121 / 89
Allergies : NONE Referred By :
   
Subjective : T2DM SINCE 2021,I YEAR POST MISCARRIAGE,DID NOT GAIN WT INSPITE OF HBA1C REDUCTION / INSULIN + DAONIL
Objective : 15-JUN-2026 REPORTS,FBS-88/ PPBS-84,HBA1C-8.0%,FBS 80-90 / PPBS 110-120
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC (100IU/ML)
TRESIBA 		SQ 0-0-0-12 BEDTIME
 2 MTHS
2 INJECTION INSULIN ASPART (100IU)
NOVORAPID (INJ) 		SC 6-6-6 BBF/ BL/BD
 2 MTHS
3 TABLET GLIBENCLAMIDE 5 MG
DAONIL 5 MG 		ORAL 1-0-1 BBF/BD
 2 MTHS
4 GLYCOMET SR 1 GM ORAL 1-0-1 BBF / BD
 2 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 16/Aug/2026
Tests Suggested For Next Visit : HBA1C / FBS / PPBS / RFT / LIPID PROFILE / URINE FOR ALBUMIN:CREAT RATIO > 2 MTHS,RETINA TEST FOR DIABETIC RETINOPATHY
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: